Larvol Delta - A-Modular-Phase-III-Multicentre-Study-to-Evaluate-AZD4045-in-Participants-With-Relapsed-or-Refractory-Multiple-Myeloma

Darzalex (daratumumab) - J&J

AZD4045 - AstraZeneca

Proleukin (aldesleukin) - Iovance Biotherap

http://clinicaltrials.gov/ct2/show/NCT07681596

Aug 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next